S&P 500 Healthcare Sector SEC Filings — May 01, 2026

01-05-2026

Cinemark Holdings, Inc. reported first quarter 2026 results with total revenue increasing 18.9% YoY to $643.1 million, Adjusted EBITDA rising 143% to $88.5 million, and net loss attributable to common stockholders narrowing 83.5% to $(6.4) million. The company achieved record domestic food & beverage per patron of $8.58 and entertained 39 million patrons. However, it posted negative operating cash flow of $(20.4) million, free cash flow of $(58.1) million, a decline in international attendance to 14.9 million from 16.0 million, and lower international Adjusted EBITDA of $13.8 million versus $16.4 million.

• ·Net leverage ratio of 2.6x as of March 31, 2026
• ·U.S. theaters: 301 (4,219 screens); International: 194 theaters (1,401 screens)
• ·Cash flows used for operating activities: $(20.4) million Q1 2026 vs $(119.1) million Q1 2025
• ·Total assets: $4,345.8 million as of March 31, 2026
• ·Total equity: $389.7 million as of March 31, 2026

01-05-2026

News Corporation filed an 8-K on May 1, 2026, reporting on disclosures made to the Australian Securities Exchange (ASX) regarding its ongoing stock repurchase program, which authorizes up to $1 billion in aggregate repurchases of Class A (NWSA) and Class B (NWS) common stock. The disclosures for specific dates are attached as Exhibits 99.1 and 99.2, with no specific transaction details provided in the filing body. Forward-looking statements note potential repurchases subject to market conditions and other factors.

• ·Date of earliest event reported: April 30, 2026
• ·Filing items: 8.01 (Other Events) and 9.01 (Financial Statements and Exhibits)
• ·Securities registered on Nasdaq Global Select Market: NWSA (Class A, $0.01 par value), NWS (Class B, $0.01 par value)

01-05-2026

Ryan Specialty Holdings, Inc. reported Q1 2026 total revenue of $795,229 up 15% YoY from $690,166, driven by net commissions and fees growth of 16% to $782,903, though fiduciary investment income declined 12% to $12,326. Operating income fell 6% YoY to $94,596 amid a $41,336 swing in change in contingent consideration to an expense of $27,294 and higher compensation costs, but net income attributable to RYAN swung to a profit of $17,646 from a $27,642 loss. EPS improved to $0.13 diluted from ($0.22), while cash flows from operations worsened to $(167,411) from $(142,825).

• ·Income tax expense sharply declined to $6,508 from $55,430 YoY.
• ·Change in contingent consideration swung to expense of $27,294 from a $14,042 gain YoY.
• ·Class A common stock repurchases totaled $40,019 with 982,073 shares retired.
• ·Cash and equivalents decreased QoQ to $154,650 from $158,322.
• ·Total stockholders’ equity declined QoQ to $1,219,054 from $1,254,051.

01-05-2026

Boston Scientific reported Q1 2026 net sales of $5,203 million, up 11.6% YoY from $4,663 million, with gross profit rising 12.6% to $3,614 million and net income surging 99.3% to $1,339 million driven by a $176 million tax benefit. Operating income grew 19.5% YoY to $1,101 million; however, operating cash flow declined 35.5% to $348 million from $541 million, leading to a net decrease in cash and equivalents to $1,453 million from $1,965 million QoQ. The company completed the Nalu Medical acquisition for $588 million.

• ·Acquisitions payments: $523 million in Q1 2026 vs $239 million in Q1 2025.
• ·Investing cash used: $591 million in Q1 2026 vs $500 million in Q1 2025.
• ·Total stockholders' equity increased to $25,864 million as of March 31, 2026 from $24,233 million as of Dec 31, 2025.

01-05-2026

Newell Brands reported first quarter 2026 net sales of $1.5 billion, down 1.1% YoY with core sales declining 3.5%, driven by declines in Home & Commercial Solutions (-6.9% core) and Outdoor & Recreation (-5.7% core), while Learning & Development grew 2.0% core. Gross margin expanded to 33.1% from 32.1% and normalized operating margin improved to 4.8% from 4.5%, though normalized net loss widened to $21 million from $6 million. The company raised its full-year 2026 outlook for net sales to flat to 2% (previously -1% to 1%), core sales to -1% to 1%, and normalized EPS to $0.56 to $0.60.

• ·Year-to-date operating cash outflow $233 million vs $213 million prior year.
• ·Debt outstanding $5.0 billion and cash $201 million at Q1 2026 end (vs $4.9 billion debt and $233 million cash at Q1 2025 end).
• ·Q2 2026 outlook: net sales and core sales flat to 2%; normalized operating margin 9.6% to 10.2%; normalized EPS $0.16 to $0.19.
• ·Full year 2026 operating cash flow outlook maintained at $350 million to $400 million.

01-05-2026

In Q1 2026, Bank of New York Mellon reported net income applicable to common shareholders of $1,562 million, up approximately 36% YoY from $1,149 million, with total revenue increasing 13% to $5,409 million driven by 11% YoY growth in fee and other revenue to $4,039 million and 18% rise in net interest income to $1,370 million. AUC/A grew 12% YoY to $59.4 trillion, while AUM increased 6% YoY to $2.1 trillion. However, AUM declined QoQ from $2.2 trillion, full-time employees decreased to 47,200 from 48,100 QoQ and 51,000 YoY, and regulatory capital ratios like Standardized CET1 fell to 11.0% from 11.9% QoQ.

• ·Return on common shareholders’ equity (annualized) 16.1% in Q1 2026 vs 12.6% Q1 2025
• ·Net interest margin 1.38% flat QoQ and up 8 bps YoY
• ·Common dividend per share $0.53, payout ratio 24%
• ·Average liquidity coverage ratio (LCR) 111%

01-05-2026

Bridgewater Bancshares, Inc. held its annual shareholder meeting on April 28, 2026, with 23,627,693 shares present, representing 84.92% of the 27,824,565 outstanding common shares and constituting a quorum. All eleven director nominees were elected with strong majorities (votes for ranging from 20,172,001 to 20,742,088, withheld under 827,403 each). Shareholders approved the non-binding advisory vote on 2025 executive compensation (20,244,780 for), the 2026 Equity Incentive Plan (14,768,670 for vs. 6,169,077 against), and ratification of RSM US LLP as auditors for 2026 (23,627,278 for).

• ·Record date for shareholder meeting: February 27, 2026
• ·Proposal 2 (exec comp): 641,268 votes against, 113,356 abstentions
• ·Proposal 3 (Equity Plan): 61,657 abstentions
• ·Proposal 4 (auditor): 139 votes against, 276 abstentions, no broker non-votes

01-05-2026

Civeo reported first quarter 2026 revenues of $172.7 million, up 20% YoY from $144.0 million, and Adjusted EBITDA of $22.5 million, up 78% YoY from $12.7 million, with Australian segment revenues increasing 19% to $123.0 million and Canadian segment revenues rising 23% to $49.6 million amid higher occupancy and cost reductions. However, the company recorded a net loss of $3.8 million, improved from $9.8 million YoY but still negative, negative operating cash flow of $9.7 million, and total debt increased to $212.3 million from $182.8 million at year-end. Post-quarter, Civeo repurchased 0.5 million shares for $14.4 million and amended its credit agreement to extend maturity to April 2030 and raise revolving capacity to $285 million.

• ·Raised full year 2026 revenue guidance to $675 million to $700 million from prior $650 million to $700 million; maintained Adjusted EBITDA guidance of $85 million to $90 million and capex of $25 million to $30 million.
• ·Net leverage ratio of 2.2x as of March 31, 2026.
• ·Completed approximately 96% of April 2025 share repurchase program authorization.
• ·Australian results include $12.0 million positive FX impact on revenues from strengthened AUD.
• ·Canadian segment Adjusted EBITDA improved to $5.2 million from negative $0.8 million YoY.

01-05-2026

SCI Engineered Materials, Inc. reported Q1 2026 revenue of $8,160,362, more than doubling YoY from $3,500,232 (+133%), driving net income to $462,262 (+49% YoY). However, gross margin declined to 25% from 31% YoY due to higher cost of revenue scaling, and a one-time fraud expense of $562,026 significantly increased operating costs. Cash from operations rose slightly to $1,178,205 (+26% YoY), with total assets expanding to $20.2M from $17.3M at year-end 2025.

• ·Earnings per share basic and diluted increased to $0.10 from $0.07 YoY.
• ·Customer deposits increased to $3,556,441 from $829,158 QoQ, signaling strong future billings.
• ·Purchase of treasury stock for $267,500 during Q1 2026.
• ·Net cash provided by operating activities $1,178,205 vs $933,353 YoY (+26%).

01-05-2026

Burke & Herbert Financial Services Corp. (BHRB) completed its merger with LINKBANCORP, Inc. (LNKB), whereby LNKB merged into Burke & Herbert, and LINKBANK merged into Burke & Herbert Bank & Trust Company, effective May 1, 2026. This transaction positions Burke & Herbert as the holding company for a bank with nearly 100 branches across Delaware, Kentucky, Maryland, Pennsylvania, Virginia, and West Virginia. No financial metrics or performance impacts were disclosed in the announcement.

• ·Filing items: 2.01, 5.02, 5.03, 8.01, 9.01
• ·Merger effective date: May 1, 2026
• ·Burke & Herbert headquartered in Alexandria, Va., oldest continuously operating bank under original name in greater Washington, D.C. area

01-05-2026

MH & Associates Securities Management Corp /ADV disclosed $114597853 in total 13F securities across 98 holdings as of March 31, 2026, in its 13F-HR filing submitted on May 1, 2026. All positions are held with sole voting and disposition power. Largest holdings by value include VanEck Merk Gold ETF ($5913759), Phillips 66 ($4429889), Pfizer Inc ($4415215), Chevron Corporation ($4405522), and Halliburton Co ($4407274).

• ·Report period end date: 2026-03-31
• ·Filing date: 2026-05-01
• ·All holdings reported with sole voting and sole disposition power (no shared or other powers)

01-05-2026

On May 1, 2026, Hanmi Financial Corporation, parent of Hanmi Bank, distributed a slide presentation to analysts and prospective investors outlining its operating and growth strategies and financial performance, furnished as Exhibit 99.1 under Item 7.01 Regulation FD Disclosure. The filing emphasizes that the information is not deemed 'filed' under the Exchange Act and includes standard forward-looking statements with associated risks. No specific financial metrics or period comparisons are detailed in the filing itself.

01-05-2026

New Republic Capital, LLC filed its 13F-HR on May 1, 2026, reporting total equity holdings valued at $296,689,597 as of March 31, 2026, across 312 positions, all held with sole voting authority. Top holdings include GMO US Quality ETF at $18,301,821, Morgan Stanley at $17,117,696, Apple Inc. at $10,700,689, Berkshire Hathaway at $7,897,695, and NVIDIA at $7,479,215. No prior period data is provided in the filing for comparison.

• ·All 312 positions held with sole voting authority; no shared voting authority reported
• ·Business address: 521 East Morehead Street, Suite 100, Charlotte, NC 28202
• ·Phone: 704-626-1526
• ·SEC file number: 028-23364

01-05-2026

01-05-2026

Strategic Financial Partners, Ltd. filed its 13F-HR report on May 1, 2026, disclosing 81 equity and ETF holdings totaling $231,502,154 as of March 31, 2026, with no changes from the prior quarter. The portfolio is diversified across individual stocks like Apple Inc. ($1,377,034), Microsoft Corp. ($1,578,656), and NVIDIA Corp. ($342,730), and heavily weighted in ETFs such as SPDR ($45,260,465 position) and Vanguard Russell 1000 Growth ($15,749,680). All positions are held with sole investment discretion.

• ·All 81 holdings managed with sole voting and investment discretion (SH SOLE 0 0)
• ·Report filed under SEC file number 028-24214
• ·No put or call options reported

01-05-2026

Steadview Capital Management LLC disclosed total holdings of $226619666 across 12 positions in its 13F-HR filing as of March 31, 2026. Top holdings by market value include Carvana Co Cl A ($46106971), Robinhood Markets Inc Com Cl A ($44982284), and AppLovin Corp Com Cl A ($35601100). The portfolio features tech and fintech names such as DoorDash, Shopify, and Palantir with no prior period data provided for comparisons.

• ·Filing date: May 01, 2026
• ·Report period end: March 31, 2026
• ·All holdings reported as sole shared power with zero shared, voting, or other power

01-05-2026

For the three months ended March 31, 2026, Matthews International's sales fell 39.5% YoY to $258,619 thousand from $427,629 thousand, driven by the divestiture of Brand Solutions (sales $0 vs $141,174 thousand) and declines in Industrial Technologies (down 46.4% to $43,362 thousand), though Memorialization grew 4.6% to $215,257 thousand. Six-month sales declined 34.5% YoY to $543,382 thousand from $829,471 thousand, but operating profit rose sharply to $94,349 thousand from $11,622 thousand due to a $109,264 thousand gain on divestitures, swinging net income to a $21,795 thousand profit from a $12,388 thousand loss—however, Q1 net loss widened to $21,834 thousand from $8,916 thousand amid higher interest and debt extinguishment costs.

• ·Gross profit three months 2026: $101,984 thousand (down 29.2% YoY from $144,112 thousand)
• ·Interest expense six months 2026: $24,675 thousand (down from $31,547 thousand YoY)
• ·Loss on debt extinguishment six months 2026: $16,343 thousand
• ·Net cash provided by investing activities six months 2026: $239,659 thousand (vs used $3,895 thousand prior year)
• ·Dividends paid six months 2026: $17,535 thousand
• ·Total shareholders' equity March 31, 2025: $408,240 thousand

01-05-2026

Farrow Financial, Inc. filed its Form 13F-HR on May 1, 2026, disclosing holdings as of March 31, 2026, with a total portfolio value of $176,083,566 across 53 positions, all held with sole voting power. Top holdings include iShares Core S&P Total Stock ETF at $13,146,859, iShares ESG Aware MSCI USA ETF at $12,883,317, and iShares MSCI Intl Value Factor ETF at $11,161,469. No prior period comparisons or performance changes are provided in the filing.

• ·All 53 positions held with sole voting power (no shared or none reported).
• ·Berkshire Hathaway Inc Del Cl A: 2 shares valued at $1,436,280.
• ·NVIDIA Corporation: 26,357 shares valued at $4,596,661.

01-05-2026

Financial Connections Group, Inc., an institutional investment manager, filed its 13F-HR report on May 1, 2026, disclosing $287.6 million in equity holdings across 251 positions as of March 31, 2026. The portfolio features heavy allocations to ETFs including Dimensional ETF Trust US Core Equity Market ETF ($43.4M, 962,980 shares) and Vanguard World Fund ESG US Stock ETF ($18.7M, 166,585 shares), with notable individual stock positions like Apple Inc. ($6.2M, 24,264 shares). All holdings are reported with sole voting power and no shared or other authority.

• ·Report covers period ending March 31, 2026.
• ·No voting authority other than sole power reported for any position.
• ·Portfolio diversified across ETFs (majority) and individual equities.

01-05-2026

Financial Counselors Inc filed a 13F-HR report disclosing its equity holdings as of March 31, 2026, with a total portfolio value of $70,859,454 across 12 positions held on a sole discretionary basis. The largest holding is iShares Core S&P 500 ETF valued at $53,648,791 (82,131 shares), followed by Vanguard FTSE Developed Markets ETF at $5,781,618 (90,225 shares). Other holdings include diversified ETFs and Apple Inc. stock at $460,375 (1,814 shares); no prior period data is provided for comparisons.

• ·All holdings are reported as sole discretionary (SH SOLE).
• ·Report period end date: March 31, 2026.
• ·Filing effective date: May 1, 2026.

01-05-2026

Castleview Partners, LLC filed its 13F-HR on May 01, 2026, disclosing holdings totaling $195,075,071 across 200 positions as of March 31, 2026, all with sole voting authority and no put/call options. The largest position is Valued Advisers TR Regan Floating Rate Income valued at $25,186,431, followed by ConocoPhillips at $6,526,476 and Apple Inc. at $6,457,940. The portfolio is diversified across ETFs, energy, technology, healthcare, and fixed income sectors.

• ·All positions held as SH SOLE with 0 put and 0 call options.
• ·No changes in voting authority reported.
• ·Filer located at 8111 Preston Road, Suite 500, Dallas, TX 75225.

01-05-2026

For Q1 2026, Enterprise Financial Services Corp reported net income of $49.4 million, slightly down 1.2% YoY from $50.0 million, with net interest income rising 12.6% YoY to $166.1 million driven by higher loan interest income, but offset by a 15.4% increase in noninterest expenses to $115.1 million and higher provision for credit losses up 39.7% to $7.2 million. Total assets decreased 0.4% QoQ to $17.2 billion, loans fell 0.9% QoQ to $11.7 billion, and deposits declined 0.6% QoQ to $14.5 billion, while stockholders' equity dropped 0.8% QoQ to $2.0 billion amid share repurchases. Comprehensive income fell sharply to $22.4 million from $65.3 million YoY due to a $27.0 million other comprehensive loss.

• ·Allowance for credit losses on loans increased to $142.1 million from $140.0 million QoQ.
• ·Tax credit income recorded a loss of $0.2 million in Q1 2026 vs $2.6 million gain YoY.
• ·Net cash provided by operating activities $58.5 million vs $40.0 million YoY.
• ·Common stock dividends $0.33 per share in Q1 2026 vs $0.29 YoY.

01-05-2026

Senti Holdings, Inc., Senti Biosciences, Inc., and Senti Biosciences Holdings, Inc. entered into a Securities Purchase Agreement dated April 27, 2026, with investors to issue Notes under exemptions from registration pursuant to Section 4(a)(2) of the Securities Act or Rule 506(b) of Regulation D. The agreement facilitates a Holding Company Reorganization, with standard representations confirming no material changes in capitalization since the 10-K for the year ended December 31, 2025 (except as scheduled), full authorization for issuance, and reservation of Issuer Common Stock equaling or exceeding 150% of maximum Exchange Shares issuable under the Notes. Transaction documents include Security Documents, Guarantees, Registration Rights Agreement, and Voting Agreements, with no reported conflicts or preemptive rights violations.

• ·Agreement exempt from registration under Section 4(a)(2) of the Securities Act or Rule 506(b) of Regulation D
• ·Issuer defined as Senti Biosciences, Inc. pre-reorganization and Senti Biosciences Holdings, Inc. post-reorganization
• ·Capitalization disclosures accurate as of Form 10-K for year ended December 31, 2025, with no changes except as in Schedule 3(b)(i)
• ·Transaction requires Stockholder Approval and SEC filings including Registration Statements and Form D

01-05-2026

Lakewood-Amedex Biotherapeutics Inc. filed an S-1 registration statement on May 1, 2026, registering up to 9,647,726 shares of its common stock (par value $0.0001 per share) for resale by selling stockholders pursuant to Rule 415. The filing includes exhibits such as warrant agreements, board agreements, registration rights agreements, and consents from independent auditors and legal counsel Lucosky Brookman LLP. It was signed by key executives including CEO Kelvin Cooper and CFO Peter Ceccacci.

• ·Company CIK: 0002079272; EIN: 205274304; Incorporated in NV; Fiscal year end: December 31.
• ·Business address: 8031 Cooper Creek Blvd., Suite 103, University Park, FL 34201.
• ·SEC file number: 333-295497.
• ·References prior S-1/A filings under Registration No. 333-292664.

01-05-2026

Cisco Systems, Inc. announced the retirement of M. Victoria Wong as Senior Vice President and Chief Accounting Officer effective May 19, 2026, with her continuing as Executive Advisor until July 25, 2026. The Board appointed Nichlas A. Fink, currently Vice President and Corporate Controller, as her successor effective May 20, 2026. In connection with the appointment, Mr. Fink will receive restricted stock units with a grant date fair value of $500,000 and enter into a standard Indemnity Agreement.

• ·Nichlas A. Fink joined Cisco in February 2016; previously served as Vice President and Corporate Controller since November 2022, Vice President of Finance from June 2021 to November 2022, and Senior Director of Finance from February 2016 to June 2021.
• ·Prior to Cisco, Mr. Fink was Vice President and Chief Accounting Officer of Pyxus International, Inc. from January 2014 to February 2016, with earlier roles at Pyxus, Nortel Networks, and Ernst & Young LLP.
• ·Indemnity Agreement with Cisco filed as Exhibit 10.1 to 8-K on January 25, 2021.

01-05-2026

Citizens Financial Group Inc/RI filed its Form 13F-HR on May 1, 2026, disclosing equity holdings as of March 31, 2026. The portfolio encompasses a broad array of securities including ETFs like 2023 ETF Series Trust and stocks such as Abbott Labs, AbbVie Inc, Apple Inc, Amazon.com Inc, and many others. No aggregate portfolio value, changes from prior periods, or performance metrics are detailed in the filing.

• ·Conformed period of report: 2026-03-31
• ·Filed as of date: 2026-05-01
• ·SEC file number: 028-05954

01-05-2026

Caribou Biosciences, Inc. filed an Amendment No. 1 to its Definitive Proxy Statement (DEFR14A) on May 1, 2026, solely to correct a clerical error: shares of common stock outstanding as of the April 20, 2026 record date changed from 98,682,370 to 98,258,898, with conforming updates to beneficial ownership percentages on page 41. The proxy covers the virtual 2026 Annual Meeting on June 17, 2026, proposing election of three Class II directors (Andrew Guggenhime, David Johnson, Nancy Whiting), ratification of Deloitte & Touche LLP as auditors for FY 2026, approval of an officer exculpation amendment to the certificate of incorporation, and possible adjournment. No other substantive changes were made.

• ·2026 Annual Meeting: June 17, 2026 at 7:30 a.m. PDT, virtual at www.virtualshareholdermeeting.com/CRBU2026
• ·Voting deadline: 11:59 p.m. EDT on June 16, 2026 via internet or phone
• ·Class II directors to serve until 2029 annual meeting
• ·Proposal 3: Officer exculpation per Delaware General Corporation Law

01-05-2026

Virtu Financial reported robust Q1 2026 results with total revenues of $1,095,327 thousand, up 30.7% YoY from $837,869 thousand, driven by 33.7% growth in trading income, net to $789,146 thousand and increased commissions to $186,625 thousand. Net income available to common stockholders surged 82.9% YoY to $182,309 thousand, with diluted EPS at $1.99 versus $1.08; however, operating expenses rose 11.7% YoY to $685,755 thousand, largely due to a 74.6% increase in employee compensation and payroll taxes to $208,355 thousand. Total assets expanded 24.6% QoQ to $25,115,260 thousand, though cash and equivalents declined 8.3% QoQ to $973,225 thousand.

• ·Diluted EPS $1.99 in Q1 2026 vs $1.08 in Q1 2025.
• ·Dividends declared at $0.24 per share of Class A common stock.
• ·Treasury stock purchases of $55,792 thousand in Q1 2026.
• ·Weighted average basic shares outstanding 86,093,727 in Q1 2026.

01-05-2026

SMARTFINANCIAL, INC. (SMBK) filed an S-3 shelf registration statement on May 1, 2026, to enable future offerings of common stock, preferred stock, debt securities, depositary shares, purchase contracts, units, warrants, and rights. As of March 31, 2026, the company reported consolidated total assets of $5.9 billion, total loans of $4.5 billion, total deposits of $5.2 billion, and shareholders' equity of $562.2 million. The prospectus incorporates by reference the 10-K for the year ended December 31, 2025 (filed March 16, 2026), Definitive Proxy Statement (filed April 7, 2026), and 8-K (filed March 31, 2026).

• ·Operates primarily through wholly-owned subsidiary SmartBank in East and Middle Tennessee, Alabama, Florida, and Georgia.
• ·Principal executive offices at 5401 Kingston Pike, Suite 600, Knoxville, Tennessee 37919; Tel: (865) 437-5700.
• ·Includes extensive forward-looking statement cautionary language and risk factors incorporated from recent 10-K.

01-05-2026

Capital Squared Financial LLC, an institutional investment manager based in Rockville, MD, filed its 13F-HR on May 1, 2026, disclosing U.S. equity holdings as of March 31, 2026. The portfolio features significant positions in large-cap stocks such as Microsoft Corp (517,300 shares), NVIDIA Corporation (1,534,600 shares), JPMorgan Chase & Co (410,000 shares), and Berkshire Hathaway (58,800 shares), alongside heavy allocations to ETFs including iShares Russell mid-cap and small-cap funds, Schwab Strategic Trust ETFs, and Vanguard index funds. No prior quarter data or performance comparisons are provided in the filing.

• ·Conformed period of report: 2026-03-31
• ·Filing date: 2026-05-01
• ·SEC file number: 028-26814
• ·Investment adviser number: 801-131530
• ·Public document count: 2
• ·State of incorporation: MD
• ·Fiscal year end: 12-31

01-05-2026

OceanFirst Financial Corp. (OCFC) filed a Form 8-K on May 1, 2026, under Items 7.01 (Regulation FD Disclosure) and 9.01, announcing presentations to current and prospective investors scheduled after May 1, 2026. The presentation materials are attached as Exhibit 99.1 and will be posted on the company's website at www.oceanfirst.com. The report is furnished to the SEC and not deemed filed for any purpose.

• ·Address of principal executive offices: 110 West Front Street, Red Bank, New Jersey 07701
• ·Telephone number: (732) 240-4500
• ·Securities: Common stock, $0.01 par value per share (OCFC on NASDAQ)

01-05-2026

First Western Financial, Inc. (MYFW) filed an 8-K on May 01, 2026, furnishing investor presentation materials as Exhibit 99.1 under Item 7.01 Regulation FD Disclosure. These materials may be presented at meetings with investors, analysts, and others, in whole or in part with possible modifications, during the fiscal year ending December 31, 2026. The information is not deemed 'filed' for purposes of Section 18 of the Exchange Act or incorporated by reference in other filings.

01-05-2026

Truist Financial Corporation held its 2026 Annual Meeting of Shareholders on April 28, 2026, with 89.3% quorum (1,108,291,362 shares present or by proxy out of 1,241,009,752 outstanding). All 11 director nominees were elected with strong majorities (e.g., Jennifer S. Banner received 898,963,546 votes for), management proposals including executive compensation approval (847,000,157 for), auditor ratification (1,066,976,093 for), and amendment of the 2022 Incentive Plan (892,091,335 for) passed decisively. A shareholder proposal on risks from policy misalignment was overwhelmingly rejected (16,932,625 for vs. 904,818,911 against).

• ·Broker non-votes of 176,638,697 shares applied to Proposals 1, 2, 4, and 5; none for Proposal 3 (auditor ratification).
• ·Definitive Proxy Statement filed March 16, 2026, details proposals.

01-05-2026

Moderna's Q1 2026 total revenue rose 260% YoY to $389 million from $108 million, driven by net product sales increasing 309% to $352 million. However, cost of sales surged 961% to $955 million, resulting in a wider operating loss of $1,388 million and net loss of $1,343 million (38% larger than $971 million in Q1 2025), with EPS at $(3.40) versus $(2.52). Cash and equivalents declined 26% QoQ to $1,908 million, while total assets fell to $11,488 million from $12,338 million.

• ·Stock-based compensation expense: $104 million in Q1 2026 (down from $115 million YoY)
• ·Net cash used in operating activities improved to $630 million from $1,037 million YoY
• ·Investing activities used $76 million net cash in Q1 2026 versus provided $730 million YoY

01-05-2026

Franklin Financial Services Corporation (FRAF) filed an 8-K on May 1, 2026, under Items 7.01 and 9.01, furnishing an investor presentation (Exhibit 99.1) for use in meetings with investors and analysts, and a shareholder presentation (Exhibit 99.2) from its annual meeting held on April 28, 2026. The filings include standard company details such as its Pennsylvania incorporation, EIN 25-1440803, Nasdaq Capital Market listing for common stock (FRAF), and principal office at 1500 Nitterhouse Drive, Chambersburg, PA 17201. No financial performance metrics or period-over-period comparisons are disclosed in the filing text.

• ·Annual meeting of shareholders held on April 28, 2026.
• ·IRS Employer Identification No.: 25-1440803.
• ·Commission File Number: 001-38884.
• ·Telephone number: (717) 264-6116.

01-05-2026

Ally Financial Inc. designated 1,000,000 shares of 7.100% Fixed-Rate Reset Non-Cumulative Perpetual Preferred Stock, Series D, each with a $1,000 liquidation preference and $0.01 par value, via a resolution by the Pricing Committee on April 27, 2026, authorized by Board resolutions on March 6, 2026. Dividends are non-cumulative, payable quarterly starting August 15, 2026, at a fixed 7.100% annual rate until the First Reset Date of August 15, 2031, after which the rate resets based on the Five-Year Treasury Rate plus 3.148%. The Series D ranks senior to common stock, on parity with existing Series B and C preferred stock, and junior to senior securities and debt.

• ·Certificate filed as EX-3.1 in 8-K on May 1, 2026, covering Items 3.03, 5.03, 8.01, 9.01
• ·Pricing Committee resolution adopted April 27, 2026; Board authorization March 6, 2026
• ·Dividend payment dates: February 15, May 15, August 15, November 15 quarterly, beginning August 15, 2026
• ·Reset Dates every 5 years starting August 15, 2031; first Reset Period to August 15, 2036
• ·Dividends computed on 360-day year of twelve 30-day months; non-cumulative and discretionary

01-05-2026

Riverview Trust Co, a Washington-based trust company, filed its 13F-HR report on May 1, 2026, disclosing equity holdings totaling $81,197,775 as of March 31, 2026, across 220 positions. The portfolio is diversified with significant exposure to ETFs including Fidelity Municipal Bond Index ETF ($15.1M) and iShares Core MSCI EAFE ETF ($13.7M), alongside individual stocks such as Apple Inc. ($864,155) and Microsoft Corp. ($1,690,937). No period-over-period changes or performance metrics are provided in the filing.

• ·Filing date: May 01, 2026
• ·Report period end date: March 31, 2026
• ·Holdings include 169 sole discretionary positions and several defined-benefit positions
• ·Largest stock holding by value: Microsoft Corp 4,568 shares valued at $1,690,937

01-05-2026

Cullinan Associates Inc filed its 13F-HR on May 1, 2026, reporting 207 equity holdings totaling $1236401866 as of March 31, 2026, all under sole discretion with no shared voting or investment power indicated. Top positions include Apple Inc (400906 shares, $101745985), Coca-Cola Company (1312987 shares, $99852685), and Microsoft Corp (156407 shares, $57897146). No period-over-period changes or performance metrics are provided in the filing.

• ·All 207 holdings reported as SOLE (sole voting and investment power)
• ·Report period end: March 31, 2026
• ·No other investment discretion (shared or none) reported for listed positions

01-05-2026

Glacier Bancorp reported strong YoY growth in net income to $82.1M (up 50.5% from $54.6M) and net interest income to $268.7M (up 41.5% from $190.0M), driven by higher interest income from commercial and residential loans. However, total assets declined 0.8% QoQ to $31.7B, non-interest expenses rose sharply 32.5% YoY to $200.5M due to elevated compensation and other costs, and comprehensive income fell to $73.2M from $100.8M YoY amid unrealized losses on securities.

• ·Provision for credit losses decreased to $6.1M from $7.8M YoY.
• ·Basic and diluted EPS both $0.63 vs $0.48 YoY; dividends declared per share steady at $0.33.
• ·Net cash provided by operating activities increased to $87.9M from $52.4M YoY.
• ·Federal Home Loan Bank advances fully repaid ($440M) during the quarter.

01-05-2026

Alerus Financial Corp reported net income of $22,971 thousand for the three months ended March 31, 2026, a 72.6% YoY increase from $13,315 thousand, bolstered by net interest income growth to $44,912 thousand (+9.2% YoY) and a $4,883 thousand credit loss recovery versus a $863 thousand provision last year. However, total interest income declined 1.8% YoY to $66,977 thousand, loans decreased 0.3% QoQ to $4,034,744 thousand, and other comprehensive income turned negative at $(2,081) thousand. Total assets grew 1.1% QoQ to $5,287,971 thousand, driven by deposit expansion, while noninterest expenses remained essentially flat at $50,392 thousand.

• ·Diluted EPS of $0.89 in Q1 2026, up from $0.52 YoY.
• ·Common stock repurchased for $6,536 thousand in Q1 2026.
• ·Dividends declared per common share $0.21 in Q1 2026, up from $0.20.

01-05-2026

On April 27, 2026, Cineverse Corp. entered into an Exchange Agreement with OCI-Cinedigm, LLC, a holder of its Series A Preferred Stock, to issue up to 1,500,000 shares of Class A Common Stock in exchange for the holder's 3.118 shares of Preferred Stock, executed in five equal tranches starting May 1, 2026. The number of Common Stock shares per tranche is determined by dividing the value of the exchanged Preferred Stock by the 5-day volume weighted average price preceding the exchange, with exchanged Preferred shares immediately retired. The Common Stock issuance qualifies as an unregistered sale under Section 3(a)(9) of the Securities Act.

• ·Exchange commences May 1, 2026
• ·Exchanged Preferred Stock shares will be retired and restored to authorized but unissued status
• ·Exchange Agreement filed as Exhibit 10.1

01-05-2026

Compass Financial Services Inc filed its 13F-HR on May 1, 2026, disclosing 56 equity holdings as of March 31, 2026, all on a sole discretionary basis with no other managers reported. The portfolio features significant allocations to ETFs such as State Street (e.g., $36,286,912 position) and WisdomTree ($19,994,506), alongside common stocks like Apple Inc ($1,507,435 for 5,939 shares), Microsoft Corp ($733,682), and NVIDIA Corp ($217,519). No changes, performance metrics, or period-over-period comparisons were disclosed in the filing.

• ·Filing CIK: 0002039088
• ·Business address: 4801 Westown Parkway, West Des Moines, IA 50266
• ·SEC file number: 028-24639

01-05-2026

CEL-SCI Corporation, a late-stage biotech firm focused on Multikine (Phase III for head and neck cancer) and LEAPS technology, filed an S-1/A amendment to register up to 4,885,993 shares of common stock and an equal number of pre-funded warrants on a best-efforts basis via placement agent ThinkEquity LLC, assuming a $3.07 per share price based on April 30, 2026 closing. The offering has no minimum proceeds requirement, may result in significantly reduced funds if undersubscribed, and terminates on September 30, 2026 (extendable 30 days), highlighting high speculation and risks as noted. It allows certain buyers to elect pre-funded warrants to avoid exceeding 4.99% or 9.99% ownership thresholds.

• ·Registration No. 333-295168
• ·Filing date: May 1, 2026
• ·Offering on delayed or continuous basis pursuant to Rule 415
• ·Smaller reporting company and non-accelerated filer status
• ·No escrow, trust, or minimum offering amount required for closing